“Deucravacitinib Long-term Efficacy With Continuous Treatment in Plaque Psoriasis: 2-Year Results From the Phase 3 POETYK PSO-1 and PSO-2 Trials” (2023) SKIN The Journal of Cutaneous Medicine, 7(6), p. s243. doi:10.25251/skin.7.supp.243.